During the past decade, Erie Retinal Surgery conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Erie Retinal Surgery" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Bayer" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "EyePoint Pharmaceuticals, Inc." with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Erie Retinal Surgery" #1 collaborator was "CBCC Global Research" with 1 trials as a collaborator, "Novartis Pharmaceuticals" with 1 trials as a collaborator, "ORA, Inc." with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Erie Retinal Surgery" are "Age-Related Macular Degeneration" (2 trials), "Diabetic Retinopathy" (2 trials), "Diabetic Macular Edema" (1 trials), "Dry Age-related Macular Degeneration" (1 trials) and "Geographic Atrophy" (1 trials). Many other conditions were trialed in "Erie Retinal Surgery" in a lesser frequency.

Most popular intervention types in "Erie Retinal Surgery" are "Drug" (6 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)" (1 trials), "Aflibercept VEGF Trap-Eye (Eylea, BAY86-5321)" (1 trials), "BI 765128" (1 trials), "Fluocinolone Acetonide Intravitreal Implant 0.18 mg" (1 trials) and "GT005: High Dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Erie Retinal Surgery" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Erie Retinal Surgery". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Erie Retinal Surgery, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Erie Retinal Surgery, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".